Utah Medical Products, Inc. UTMD

SALT LAKE CITY, UT / ACCESS Newswire / September 25, 2026 / (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75. The conditions of the Offer are explained in detail in the SEC Form TO Offer to Purchase and Letter of Transmittal filed with the SEC athttps://www.

SALT LAKE CITY, UT / ACCESS Newswire / September 24, 2026 / (NASDAQ:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share price represents a 17% premium over the average daily closing price of the stock during the last twelve months, and a 21% premium over the average daily closing price of the stock during the last twenty-four months.

Utah Medical Products Inc (NASDAQ:UTMD) recently announced a total dividend of $0.31 per share. The ex-dividend date is set for 2026-09-17, and the cash dividend of $0.31 per share is payable on 2026-10-05. For investors, the ex-dividend date is the cutoff: shareholders must own the stock before this date to qualify for the payment, while the paydate marks when the cash actually arrives.

SALT LAKE CITY, UT / ACCESS Newswire / September 15, 2026 / (Nasdaq:UTMD) announces today that it intends to repurchase at a price of $75.00 per share up to 650,000 of its shares, if tendered and not withdrawn by stockholders on or before October 7, representing approximately 20% of its currently outstanding shares.

SALT LAKE CITY, UT / ACCESS Newswire / August 31, 2026 / Femcare Ltd. ("Femcare"), a wholly-owned subsidiary of (Nasdaq:UTMD), announces that it has purchased the entire ordinary share capital of Orion Medical Supplies Ltd ("ORION") of the United Kingdom.

SALT LAKE CITY, UT / ACCESS Newswire / July 23, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) reports second calendar quarter (2Q) and first half (1H) 2026 financial results with a continued decline in overall revenues in comparison to the same ...

SALT LAKE CITY, UT / ACCESS Newswire / May 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on July 3, 2026 to ...

SALT LAKE CITY, UT / ACCESS Newswire / April 23, 2026 / In the first calendar quarter (1Q) of 2026, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results which were consistent with its previously announced projections for calendar year ...